top of page

Big deals and small molecules with the CEO of Nimbus Therapeutics

Nimbus Therapeutics CEO Jeb Keiper describes his company’s programs and the future of small molecule drug development under the Inflation Reduction Act.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page